Kala Bio Inc (KALA)

Sep 03, 2026

Kala Bio secures exclusive U.S. rights to Virotek genetic tests By Investing.com - Investing.com Nigeria

Sep 03, 2026

Sep 03, 2026

KALA Stock Update: Exclusive U.S. Distribution Deal with Virotek Highlights Growth Challenges - GuruFocus

Sep 03, 2026

Sep 03, 2026

Kala Bio Signs Exclusive U.S. Distribution Agreement for Virotek Ophthalmology Genetic Tests - Yahoo Finance

Sep 03, 2026

Sep 03, 2026

For one year, eye-condition genetic tests will have one U.S. seller, Kala Bio. Virotek still processes samples. - Stock Titan

Sep 03, 2026

Sep 01, 2026

Kala Bio Targets Near-Term Revenue With Virotek Ophthalmology Genetic Testing Partnership - Yahoo Finance

Sep 01, 2026

Sep 01, 2026

Kala Bio, Virotek enters LOI for distribution agreement - TipRanks

Sep 01, 2026

Sep 01, 2026

KALA Bio (KALA) Signs Exclusive Distribution LOI with Virotek, F - GuruFocus

Sep 01, 2026

Sep 01, 2026

Kala Bio, Virotek Outline Exclusive U.S. Genetic Testing | KALA Stock News - Stock Titan

Sep 01, 2026

Aug 29, 2026

KALA BIO Faces Nasdaq Listing Compliance Uncertainty - The Globe and Mail

Aug 29, 2026

Aug 28, 2026

KALA BIO Faces Nasdaq Delisting Risk on Minimum Bid Price Failure - Minichart

Aug 28, 2026

Aug 28, 2026

KALA BIO Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Aug 28, 2026

Aug 21, 2026

KALA (KALA) Close: Ends Down by 2.39% at $0.82 at the Close; Boundary Watch: Traders Can Monitor the $0.78-$0.86 Range in the Latest ReadingLow Vol ETF - vinanet.vn

Aug 21, 2026

Aug 20, 2026

KALA (KALA) Technicals: Moves 6.67% Down to $0.84; Technical Setup: the Supplied Trading Band Runs From $0.80 to $0.88 at the CloseProtective Put - vinanet.vn

Aug 20, 2026

Aug 20, 2026

KALA Stock Hits Record Low – Firm Announces Reverse Split After Shares Fail To Surpass The $1 Mark - Stocktwits

Aug 20, 2026

Aug 20, 2026

KALA BIO: Q2 Earnings Snapshot - AOL.com

Aug 20, 2026

Aug 19, 2026

KALA BIO Q2 Net Loss Narrows to $1.58 Million Amid Sharp Spending Cuts - Minichart

Aug 19, 2026

Aug 19, 2026

KALA BIO, Inc. Q2 2026: Net loss $(1.58M), EPS $(21.32) — 10-Q Summary - TradingView

Aug 19, 2026

Aug 19, 2026

KALA: Net loss narrowed sharply as focus shifted to AI platform, with liquidity supported by note receivable - TradingView

Aug 19, 2026

Aug 19, 2026

KALA BIO (KALA) pivots to biotech AI with $229K on hand - Stock Titan

Aug 19, 2026

Aug 19, 2026

KALA (KALA) Session: Retreats 0.97% to $0.89; Next Session: Price Remains Between $0.85 Support and $0.93 Resistance in the Latest ReadingRTH Profile - vinanet.vn

Aug 19, 2026

Aug 18, 2026

KALA Q4 2025 Earnings: Loss Narrows to -33.5 Per Share, Beating Estimates by 54.38Performance Review - vinanet.vn

Aug 18, 2026

Aug 14, 2026

KALA BIO Announces Brief Delay in Quarterly Filing - TipRanks

Aug 14, 2026

Aug 14, 2026

KALA BIO (KALA) delays June 30, 2026 Form 10-Q to finalize liquidity analysis - Stock Titan

Aug 14, 2026

Aug 13, 2026

KALA Q4 2025 Earnings: Narrower-Than-Expected Loss Delivers a 54.38 EPS SurpriseDividend Growth Analysis - vinanet.vn

Aug 13, 2026

Aug 12, 2026

KALA BIO Inc (KALA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 12, 2026

Aug 06, 2026

KALA BIO (KALA) Climbs 4.4% to $0.73 as Bulls Target $0.77 ResistanceSell Signal Alerts - dars.gov.et

Aug 06, 2026

Aug 05, 2026

KALA Q2'26 Earnings: EPS estimate is (6.00) USD - TradingView

Aug 05, 2026

Aug 02, 2026

KALA BIO Inc. (KALA) Gains 3.59% to $0.76 — Approaches Key Resistance at $0.80Systematic Flow - vinanet.vn

Aug 02, 2026

Jul 31, 2026

KALA BIO Inc (KALA) Institutional Confidence - TradingKey

Jul 31, 2026

Jul 30, 2026

KALA Q2'26 Earnings: revenue estimate is 0 USD - TradingView

Jul 30, 2026

Jul 27, 2026

KALA BIO Inc (KALA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026

Jul 27, 2026

KALA BIO Inc (KALA) Cash Flow - TradingKey

Jul 27, 2026

Jul 27, 2026

KALA BIO Inc (KALA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Jul 26, 2026

KALA BIO Inc (KALA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 26, 2026

Jul 26, 2026

KALA Q4 2025 Earnings: Significant Beat on EPS Despite No Reported RevenueRevenue Inflection Point - vinanet.vn

Jul 26, 2026

Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026

Jul 25, 2026

KALA BIO Inc (KALA) Balance Sheet - TradingKey

Jul 25, 2026

Jul 25, 2026

KALA|KALA BIO Inc|Price:0.740|Chg%:-0.003 - TradingKey

Jul 25, 2026

Jul 25, 2026

KALA|KALA BIO Inc|Price:0.812|Chg%:-0.004 - tradingkey.com

Jul 25, 2026

Jul 24, 2026

KALA BIO, Inc. Revenue Breakdown – NASDAQ:KALA - TradingView

Jul 24, 2026

Jul 24, 2026

KALA|KALA BIO Inc|Price:0.634|Chg%:+0.024 - TradingKey

Jul 24, 2026

Jul 24, 2026

KALA BIO Inc (KALA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026

Jul 23, 2026

Kala Bio, Inc. Files Form 8-K with SEC Detailing Nasdaq Listing and Corporate Information - Minichart

Jul 23, 2026

Jul 23, 2026

KALA Bio (KALA) Slides 13% as Sellers Test Critical Floor Near $0.61Volatility Smile - vinanet.vn

Jul 23, 2026

Jul 22, 2026

Kala Bio Files ATM Offering Of Up To $250 Million In Common StockSEC Filing - TradingView

Jul 22, 2026

Jul 16, 2026

Frontier tech research, news & data - MLQ.ai

Jul 16, 2026

Jul 13, 2026

KALA BIO Shares Plunge Over 7% as Stock Nears Critical Support LevelGamma Flip Level - vinanet.vn

Jul 13, 2026

Jul 06, 2026

Kala Bio announces 1-for-50 reverse stock split effective Friday - Investing.com

Jul 06, 2026

Jul 02, 2026

Form 13D/A KALA BIO For: 2 July By Investing.com - Investing.com Nigeria

Jul 02, 2026

Jul 02, 2026

David Lazar trims KALA BIO (KALA) stake to 3.9% with 719,404 shares - Stock Titan

Jul 02, 2026

Jul 02, 2026

Price to earnings forward of KALA BIO, Inc. – NASDAQ:KALA - TradingView

Jul 02, 2026

Jun 27, 2026

KALA BIO Inc. (KALA) Holds Near Support After Slight Decline: Key Levels in FocusVanna Flow - dars.gov.et

Jun 27, 2026